A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

INTRODUCTION: Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Giorgio L, Di Matteo, Sergio, Peris, Ketty, Fargnoli, Maria Concetta, Esposito, Maria, Mazzotta, Annamaria, Chimenti, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169985/
https://www.ncbi.nlm.nih.gov/pubmed/21935307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169985/
https://www.ncbi.nlm.nih.gov/pubmed/21935307

Ejemplares similares